Checkpoint kinase‑1 inhibition and etoposide exhibit a strong synergistic anticancer effect on chronic myeloid leukemia cell line K562 by impairing homologous recombination DNA damage repair

Zhuoyi Fan(Tongji Hospital), Jun Xu(Shanghai East Hospital)
Oncology Reports
September 7, 2020
Cited by 17


Related Papers